Quick Answer
NANOVIRICIDES, INC. reported R&D Expense of $5.55 million for fiscal year 2025.
NANOVIRICIDES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.55M | +2.1% |
| 2024 | $5.44M | -14.9% |
| 2023 | $6.39M | +10.5% |
| 2022 | $5.78M | -5.4% |
| 2021 | $6.11M | +30.2% |
| 2020 | $4.70M | -20.7% |
| 2019 | $5.92M | +0.1% |
| 2018 | $5.91M | -9.9% |
| 2017 | $6.57M | +30.6% |
| 2016 | $5.03M | +37.4% |
| 2015 | $3.66M | -28.7% |
| 2014 | $5.13M | +19.5% |
| 2013 | $4.29M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.12M | -3.3% | +12.6% |
| September 30, 2025 | $993.1K | -48.6% | -22.6% |
| March 31, 2025 | $1.28M | +5.6% | +10.9% |
| December 31, 2024 | $1.16M | -26.5% | -40.2% |
| September 30, 2024 | $1.93M | +31.8% | +59.1% |
| March 31, 2024 | $1.21M | +1.6% | -22.8% |
| December 31, 2023 | $1.57M | +34.4% | +7.3% |
| September 30, 2023 | $1.47M | +31.8% | +22.6% |
- NANOVIRICIDES, INC. showed an increase of +2.1% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, NANOVIRICIDES, INC.’s r&d expense has grown by 29.3% (from $4.29 million to $5.55 million).
- The most recent figure is from NANOVIRICIDES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: